Key Findings:  A randomized, double-blind, placebo-controlled trial demonstrated that a combined plant extract (CPE) formulation showed potential in reducing moderate to severe long COVID symptoms, particularly fatigue and post-exertional malaise, with an acceptable safety profile, though larger-scale studies are needed for validation.
Type of Study:  Double Blind Clinical Trial
Study Sample Size:  66
Study Result:  Positive
Research Location(s):  Thailand
Year of Pub:  2024
Cannabinoids Studied:  Cannabinoid (unspecified)
Phytocannabinoid Source:  Cannabis Flower derived
Terpenes Studied:  Limonene
Citation:  Lukkunaprasit T, et al. Impact of combined plant extracts on long COVID: An exploratory randomized controlled trial. Complement Ther Med. 2024; 87:103107. doi: 10.1016/j.ctim.2024.103107
Authors:  Lukkunaprasit T, Satapornpong P, Kulchanawichien P, Prawang A, Limprasert C, Saingam W, Permsombut C, Panidthananon W, Vutthipong A, Lawanprasert Y, Pourpongpan P, Wongwiwatthananukit S, Songsak T, Pradubyat N